NASDAQ: ANTX
An2 Therapeutics Inc Stock Ownership - Who owns An2 Therapeutics?

Insider buying vs selling

Have An2 Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eric EasomChief Executive Officer2025-06-0210,000$1.07
$10.67kBuy
Braden Michael Leonard10% Owner2025-05-307,000$1.03
$7.22kSell
Braden Michael Leonard10% Owner2025-05-30425,000$1.01
$429.25kSell
Braden Michael Leonard10% Owner2025-05-28200,000$1.09
$218.00kSell
Braden Michael Leonard10% Owner2025-05-282,000,000$1.16
$2.32MSell
Braden Michael Leonard10% Owner2025-05-28100,000$1.16
$116.00kSell
Margaret M. FitzpatrickDirector2025-05-288,610$1.18
$10.13kBuy
Sanjay ChandaChief Development Officer2025-01-032,957$1.34
$3.97kSell
Joshua M. EizenChief Operating Officer and Chief Legal Officer2025-01-039,663$1.34
$12.96kSell
Lucy DayChief Financial Officer2025-01-032,957$1.34
$3.97kSell

1 of 4

ANTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANTX insiders and whales buy or sell their stock.

ANTX Shareholders

What type of owners hold An2 Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bml Capital Management LLC19.05%5,749,432$6.04MInstitution
Kabeer Aziz17.38%5,243,219$5.51MInsider
Adjuvant Global Health Technology Fund LP16.55%4,994,638$5.24MInsider
Ra Capital Management LP13.50%4,074,370$4.28MInsider
Braden Michael Leonard10.66%3,217,432$3.38MInsider
Eric Easom5.46%1,647,551$1.73MInsider
Almitas Capital LLC4.35%1,313,111$1.38MInstitution
Robin Shane Readnour3.80%1,146,723$1.20MInsider
Joseph S. Zakrzewski3.50%1,057,298$1.11MInsider
Vanguard Group Inc3.43%1,035,947$1.09MInstitution

1 of 3

ANTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANTX39.55%60.45%Net SellingNet Selling
ESLA1.70%82.00%
OKUR32.02%67.98%Net BuyingNet Selling
RANI6.27%38.43%Net Selling
RNTX15.05%84.95%Net Buying

An2 Therapeutics Stock Ownership FAQ

Who owns An2 Therapeutics?

An2 Therapeutics (NASDAQ: ANTX) is owned by 47.52% institutional shareholders, 72.63% An2 Therapeutics insiders, and 0.00% retail investors. Kabeer Aziz is the largest individual An2 Therapeutics shareholder, owning 5.24M shares representing 17.38% of the company. Kabeer Aziz's An2 Therapeutics shares are currently valued at $5.51M.

If you're new to stock investing, here's how to buy An2 Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.